1. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Issue 1 (January 2018) Authors: Hakim, James G; Thompson, Jennifer; Kityo, Cissy; Hoppe, Anne; Kambugu, Andrew; van Oosterhout, Joep J; Lugemwa, Abbas; Siika, Abraham; Mwebaze, Raymond; Mweemba, Aggrey; Abongomera, George; Thomason, Margaret J; Easterbrook, Philippa; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I; Agweng, ... Journal: Lancet infectious diseases Issue: Volume 18:Issue 1(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTH-134 Setting Up An Endoscopy Unit in Northern Malawi. (17th August 2016) Authors: Nyahoda, R; Uledi, S; Kibrete, W; Nyirenda, R; O'Toole, P; Gordon, MA; Stanley, AJ Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Stevens-Johnson syndrome due to rifampicin. Issue 6096 (5th November 1977) Authors: Nyirenda, R; Gill, G V Journal: BMJ Issue: Volume 2:Issue 6096(1977) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗